Sign in
Not yet recruitingNo phase

Herbal decoction added to vessel treatment for diabetic foot ulcers

Tests Modified Simiao Yongan Decoction with standard care in adults with diabetic foot ulcers.

Key facts

Who runs it
Chengdu University of Traditional Chinese Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Clinical Efficacy of Modified Simiao Yongan Decoction and Endovascular Therapy for Diabetic Foot Ulcers
Status
Not yet recruiting
People taking part
120 people, planned
Starts
Dec 2026
Expected to end
Nov 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Modified Simiao Yongan Decoction
  • Endovascular Therapy and Standard Care
Record updated
8 September 2026

Who can take part

The trial is looking for adults with a diabetic foot ulcer who have already had a successful procedure to open leg blood vessels from the inside (endovascular intervention). They must also show the Traditional Chinese Medicine pattern called "Damp-Heat Toxins Accumulation Syndrome".

Age
18 Years and older
Sex
All
Disease stage
Diabetic foot ulcer, Rutherford classification 4-5 or Wagner classification 2-4. The person needs at least two main signs, such as a red, swollen, hot or painful limb. They also need at least one minor sign, such as a dry mouth or a red tongue with a yellow coating.
Earlier treatment
Must have successfully received a lower extremity endovascular intervention.
Main reasons for not taking part
  • Severe, uncontrolled life-threatening disease, such as severe heart failure (NYHA class III-IV), severe liver or kidney problems, or active cancer
  • Active sepsis (blood infection), extensive gangrene, or severe bone infection needing immediate major amputation of the limb
  • Allergy or severe reaction to any herb in the Modified Simiao Yongan Decoction
  • Pregnant, planning pregnancy, or breastfeeding
  • Taking part in another interventional clinical trial now or within the last 30 days
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Diagnosed with a Diabetic Foot Ulcer (DFU)
  • Assessed as Rutherford classification 4-5 or Wagner classification 2-4
  • Successfully received lower extremity endovascular intervention
  • Meets the Traditional Chinese Medicine diagnostic criteria for "Damp-Heat Toxins Accumulation Syndrome". Patients must exhibit at least two primary symptoms (red/swollen/hot/painful limb, high exudate or purulent secretion with foul odor, dark purple wound/necrotic tissue, elevated local skin temperature) and at least one secondary symptom (dry mouth/bitter taste, dry stool, red tongue with yellow greasy coating, rapid/string-taut pulse)

Who cannot take part

  • Patients with severe, uncontrolled life-threatening systemic diseases, such as severe heart failure (NYHA class III-IV), severe hepatic or renal dysfunction, or active malignancy
  • Patients with known allergies, hypersensitivity, or severe adverse reactions to any of the herbal components of the Modified Simiao Yongan Decoction
  • Patients with severe gastrointestinal disorders that would significantly impair the absorption of oral medications
  • Patients with severe cognitive impairment, psychiatric disorders, or poor compliance that would prevent them from providing informed consent or adhering to the 24-month follow-up schedule
  • Patients with active systemic sepsis, extensive gangrene, or severe osteomyelitis requiring immediate major amputation of the target limb
  • Women who are pregnant, planning to become pregnant, or currently lactating
  • Patients currently participating in, or who have participated in within the last 30 days, another interventional clinical trial

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Diabetic foot ulcer or damp-heat toxins accumulation syndrome

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study evaluates the clinical efficacy and safety of a Modified Simiao Yongan Decoction when used alongside standard endovascular therapy and wound care for the treatment of diabetic foot ulcers. The trial focuses on patients presenting with the damp-heat toxins accumulation syndrome (Rutherford 4-5 or Wagner 2-4 classifications). Enrolling 120 participants, the study aims to observe the complete ulcer healing rate, limb salvage outcomes, and improvements in patient quality of life over a 6 to 24-month follow-up period.

The 2 groups in the trial

  • Experimental GroupTreatment being tested

    Participants in this group will undergo standard endovascular intervention, receive a standardized antithrombotic regimen, and undergo standard wound care. In addition, they will receive a 1-month course of Modified Simiao Yongan Decoction granules.

    Treatment: Modified Simiao Yongan Decoction and Endovascular Therapy and Standard Care

  • Standard Treatment Control GroupExisting treatment, for comparison

    Participants in this group will undergo standard endovascular intervention, receive a standardized antithrombotic regimen, and undergo standard wound care without the addition of the herbal granules.

    Treatment: Endovascular Therapy and Standard Care

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Efficacy and Mechanism of Modified Simiao Yongan Decoction Combined With Endovascular Therapy for Diabetic Foot Ulcers (Damp-Heat Toxins Accumulation Syndrome) Based on the Vascular-Immune Microenvironment
Plain-language title
Herbal decoction added to vessel treatment for diabetic foot ulcersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07808502, who can take part
Record updated
8 September 2026